SCHEMBL9844714

SCHEMBL9844714

O=C1/C(=C\C2CCN(Cc3ccccc3)CC2)Cn2c1cc1cc(OCc3ccccc3)ccc12

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 12/20 0.50
BACE1 P56817 2/20 0.50
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9844717 1.00 ACHE (0.50) ACHEBACE1NPC1RAB9A
SCHEMBL9259916 0.92 ACHE (0.52) ACHEBACE1
SCHEMBL9259922 0.92 ACHE (0.52) ACHEBACE1
SCHEMBL9259751 0.90 ACHE (0.63) ACHEBACE1
SCHEMBL9259753 0.90 ACHE (0.63) ACHEBACE1
SCHEMBL4508009 0.85 ACHE (0.52) ACHEBACE1
SCHEMBL4508006 0.85 ACHE (0.52) ACHEBACE1
SCHEMBL9260222 0.85 ACHE (0.48) ACHEBACE1
SCHEMBL9260220 0.85 ACHE (0.48) ACHEBACE1
SCHEMBL9253207 0.85 ACHE (0.48) ACHEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0441517-A2 Tricyclic amines as novel cholinesterase inhibitors PFIZER INC. (US) 1991-08-14 EP claimed
EP-0441517-A2 Tricyclic amines as novel cholinesterase inhibitors PFIZER INC. (US) 1991-08-14 EP disclosed